{"title":"ELITE II and Val-HeFT are different trials: together what do they tell us?","authors":"K. Dickstein","doi":"10.1186/cvm-2-5-240","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":53230,"journal":{"name":"Current Controlled Trials in Cardiovascular Medicine","volume":"29 1","pages":"240 - 243"},"PeriodicalIF":0.0000,"publicationDate":"2001-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"23","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Controlled Trials in Cardiovascular Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/cvm-2-5-240","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}